Overexpression of neurotrophin receptor p75 contributes to the excitotoxin-induced cholinergic neuronal death in rat basal forebrain

Brain Research

Volumn 853, Issue 2, 2000, Pages 174-185

  Oh, Justin D ^a   Chartisathian, Karnon ^a   Chase, Thomas N ^a   Butcher, Larry L ^b  

^a Sect Clin and Exp Neuropsychol   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Apoptosis; Kainic acid lesion; Medial septum; Nerve growth factor; Nucleus of basalis of Meynert

Indexed keywords

CHOLINE ACETYLTRANSFERASE; CYCLOHEXIMIDE; DNA FRAGMENT; KAINIC ACID; MONOCLONAL ANTIBODY; NEUROTROPHIN RECEPTOR; PROTEIN P75; RECEPTOR ANTIBODY;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; FOREBRAIN; GEL ELECTROPHORESIS; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL MEMORY;

ACETYLCHOLINE; ANIMALS; ANTIBODIES; APOPTOSIS; BEHAVIOR, ANIMAL; CELL COUNT; CELL DEATH; CHOLINE O-ACETYLTRANSFERASE; CYCLOHEXIMIDE; DNA FRAGMENTATION; KAINIC ACID; MALE; MEMORY DISORDERS; MICROINJECTIONS; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, NERVE GROWTH FACTOR;

EID: 0033987763     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02054-5     Document Type: Article

References (106)

1. Armstrong D.K., Isaacs J.T., Ottaviana Y.L., Davidson N.E. Programmed cell death in an Estrogen-independent human breast cancer cell line, MDA-MB-468. Cancer Res. 52:1992;3418-3424.
2. Bamji S.X., Majdan M., Pozniak C.D., Belliveau D.J., Aloyz R., Kohn J., Causing C.G., Miller F.D. The p75 nerotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J. Cell Biol. 140:1998;911-923.
3. Barbacid M. Structural and functional properties of the Trk family of neurotrophin receptors. Receptor Activation by Antigens, Cytokines, Hormones, and Growth Factors. 766:1995;442-458.
4. Barker P.A. p75(NTR): a study in contrasts. Cell Death Differ. 5:1998;346-356.
5. Barker P.A., Shooter E.M. Disruption of NGF binding to the low-affinity neurotrophin receptor p75 reduces NGF binding to trkA or PC12 cells. Neuron. 13:1994;203-215.
6. Barrett G., Bartlett P.F. The P75 nerve growth factor receptor mediates survival or death depending on the stage of sensory neuron development. Proc. Natl. Acad. Sci. U. S. A. 91:1994;6501-6505.
7. Bigl V., Arendt T. Cholinergic neurons of the central nervous system: morphofunctional aspects. Acta Psychiatr. Scand. 366:1991;7-13.
8. Boissiere F., Lehericy S., Strada O., Agid Y., Hirsch E.C. Neurotrophin receptors and selective loss of cholinergic neurons in Alzheimer's disease. Mol. Chem. Neuropathol. 28:1996;219-223.
9. Bonfoco E., Krainc D., Ankarcrona M., Nicotera O., Lipton S.A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. U. S. A. 92:1995;7162-7166.
10. H. Braak, E. Braak, in: D.B. Caline (Ed.), Neurodegenerative Diseases, Saunders, Philadelphia, 1994, pp. 585-613.
11. Bredesen D.E., Rabizadeh S. p75 and apoptosis: Trk-dependent and Trk-independent effects. Trends Neurosci. 20:1997;287-290.
12. Bredsen D.E., Ye X., Tasinato A., Sperandio S., Wang J.J.L., Assa-Munt N., Rabizadeh S. p75(NTR) and the concept of cellular dependence: seeing how the other half die. Cell Death Differ. 5:1998;365-371.
13. Bunone G., Mariotti A., Compagni A., Morandi E., Della Valle G. Induction of apoptosis by p75 neurotrophin receptor in human neuroblastoma cells. Oncogene. 14:1997;1463-1470.
14. Butcher L.L., Semba K. Reassessing the cholinergic basal forebrain: nomenclature schemata and concepts. Trends Neurosci. 12:1989;483-485.
15. Canals J.M., Marco S., Checa N., Michels A., Perez-Navarro E., Arenas E., Alberch J. Differential regulation of the expression of growth factor, brain-derived neurotrophic factor, and neurotrophin-3 after excitotoxicity in a rat, model of Huntington's disease. Neurobiol. Dis. 5:1998;357-364.
16. Carter B.D., Kaltschmidt C., Kaltschmidt B., Offenhauser N., Bohm-Mattthaei R., Baeuerle P.A., Barde Y.-A. Selective activation of Nk-kB by nerve growth factor through the neurotrophin receptor p75. Science. 272:1996;542-545.
17. Casaccia-Bommefil P., Carter B.D., Dobrowsky R.T., Chao M.V. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature. 383:1996;716-719.
18. Casaccia-Bonnefil P., Kong H.Y., Chao M.V. Neurotrophins: the biological paradox of survival factors eliciting apoptosis. Cell Death Differ. 5:1998;357-364.
19. Chao M.V. The p75 neurotrophin receptor. J. Neurobiol. 25:1994;1373-1385.
20. Chao M.V., Casaccia-Bonnefil P., Carter B., Chittka A., Kong H., Yoon S.O. Neurotrophin receptors: mediators of life and death. Brain Res. Rev. 26:1998;295-301.
21. Choi D.W. Excitotoxic cell death. J. Neurobiol. 23:1992;1261-1276.
22. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
23. Csernansky J.G., Bardgett M.E., Sheline Y.I., Morris J.C., Olney J.W. CSF excitatory amino acids and severity of illness in Alzheimer's disease. Neurology. 46:1996;1715-1720.
24. Davies A.M., Lee K.-F., Jaenisch R. p75-deficient trigeminal sensory neurons have an altered response to NGF but not to other neurotrophins. Neuron. 11:1993;565-574.
25. Dechant G., Barde Y.A. Signalling through the neurotrophin receptor p75(NTR). Curr. Opin. Neurobiol. 7:1997;413-418.
26. Dewji N.N., Singer S.J. Specific intercellular binding of the beta-amyloid precursor protein to the presenilins induces intercellular signaling: its significance for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 95:1998;15055-15060.
27. Dobrowsky R.T., Werner M.H., Castellino A.M., Chao M.V., Hannun Y.A. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science. 265:1994;1596-1599.
28. Dunnett S.B., Everitt B.J., Robbins T.W. The basal forebrain-cortical system: interpreting the functional consequences of excitotoxic lesions. Trends Neurosci. 14:1991;494-501.
29. Dutar P., Bassant M.H., Senut M.C., Lamour Y. The septohippocampal pathway: structure and function of a central cholinergic system. Physiol. Rev. 75:1995;393-427.
30. Edelberg H.K., Wei J.Y. The biology of Alzheimer's disease. Mech. Ageing Dev. 91:1996;95-114.
31. M.M. Esiri, B.T. Hyman, C. Beyreuther, C.L. Masters, Aging and dementia, in: D.I. Graham, P.L. Lantos (Eds.), Greenfield's Neuropathology, Oxford Univ. Press, New York, pp. 1284-1410.
32. Filipcik P., Mitro A., Khuebachova M., Borkova M., Baroskova A., Fiala R., Bajo M., Novak M. The role of beta amyloid short fragments and tau proteins in the pathogenesis of Alzheimer's disease. Chem. Pap. (Chem. Zvesti). 52:1998;431-432.
33. Flilpkoqski R.K., Hetman M., Kaminska B., Kaczmarek L. DNA fragmentation in rat brain after intraperitoneal administration of kainate. NeuroReport. 5:1994;1538-1540.
34. Forloni G., Chiesa R., Smiroldo S., Verga L., Salmona M., Tagliavini F., Aneretti N. Apoptosis mediated neurotoxicity induced by chronic application of b-amyloid fragment 25-35. NeuroReport. 4:1993;523-526.
35. Frade J.M., Rodriguez-Tebar A., Barde Y.A. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature. 383:1996;166-168.
36. Gage F.H., Armstrong D.M., Williams L.R., Varon S., Bjorklund A. Morphological response of axotomized septal neurons containing only acetylcholinesterase. J. Neurosci. 3:1988;2286-2291.
37. Gage F.H., Wictorin K., Fischer W., Williams L.R., Varon S., Bjorklund A. Retrograde cell changes in medial septum and diagonal band following fimbria-fornix transection: quantitative temporal analysis. Neuroscience. 19:1986;241-255.
38. Geula C. Abnormalities of neural circuitry in Alzheimer's disease: hippocampus and cortical cholinergic innervation. Neurology. 51:1998;S18-S29. Suppl. 1.
39. Gillardon F., Wickert H., Zimmermann M. Up-regulation of bax and down regulation of bcl-2 is associated with kainate-induced apoptosis in mouse brain. Neurosci. Lett. 192:1995;85-88.
40. Gray C.W., Patel A.J. Neurodegeneration mediated by glutamate and beta-amyloid peptide: a comparison and possible interaction. Brain Res. 691:1995;169-179.
41. Greene L.A., Kaplan D.R. Early events in neurotrophin signaling via Trk and p75 receptor. Curr. Opin. Neurobiol. 5:1995;579-587.
42. Grilli M., Goffi F., Memo M., Spano P. Interleukin-1b and glutamate activate the NF-κB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J. Biol. Chem. 271:1996;15002-15007.
43. Gu J.J., Ming H., Huang B.R., Cai L.W. Expression of human low-affinity nerve growth factor receptor in mammalian neural cells and its induction of apoptosis. Acta. Biochim. Biophys. Sin. 29:1997;343-350.
44. Guzmangodinez G., Schlieb S.R. Effect of kainic acid administration to prepubescent rats on cholinergic markers in selected brain-regions of adult-rats. Neurochem. Int. 21:1992;447-453.
45. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J. Neurosci. 14:1986;2155-2162.
46. Hefti F. Pharmacology of neurotrophic factors. Annu. Rev. Pharmacol. Toxicol. 37:1997;239-267.
47. Hefti F., Knusel B., Lapchak P.A. Protective effects of nerve growth-factor and brain-derived neurotrophic factor on basal forebrain cholinergic neurons in adult-rats with partial fimbrial transections. Prog. Brain Res. 98:1993;257-263.
48. Henderson Z. Responses of basal forebrain cholinergic neurons to damages in the adult brain. Prog. Neurobiol. 48:1996;219-254.
49. Hock C., Heese K., Muller-Spahn F., Hulette C., Rosenber C., Otten U. Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease. Neurosci. Lett. 241:1998;151-154.
50. Hunot S., Brugg B., Ricard D., Michel P.P., Muriel M.-P., Ruberg M., Faucheux B.A., Agid Y., Hirsch E.C. Nuclear translocation of NF-kB is increased in dopaminergic neurons of patients with Parkinson disease. Proc. Natl. Acad. Sci. U. S. A. 94:1997;7531-7536.
51. Isackson P.J. Trophic factor response to neuronal stimuli or injury. Curr. Opin. Neurobiol. 5:1995;350-357.
52. Jenkins S.M., Johnson G.V.W. Involvement of the low affinity nerotrophin receptor (p75(NTR)) in apoptosis of differentiated PC12 cells. Neurosci. Res. Commun. 20:1997;137-146.
53. Jimenez-Jimenez F.J., Molina J.A., Gomez P., Vargas C., de Bustos F., Benito-Leon J., Tallon-Barranco A., Orti-Pareja M., Gasalla T., Arenas J. Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease. J. Neural Transm. 105:1998;269-277.
54. Johnson E.M. Jr., Osborn P.A., Taniuchi M. Destruction of sympathetic and sensory neurons in the developing rat by a monoclonal antibody against the nerve growth factor (NGF) receptor. Brain Res. 478:1989;166-170.
55. Kaltschmidt B., Uherek M., Volk B., Baeuerle P.A., Kalschmidt C. Transcription factor NF-kB is activated in primary neurons by amyloid b peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 94:1997;2642-2647.
56. Kasa P., Rakonczay Z., Gulya K. The cholinergic system in Alzheimer's disease. Prog. Neurobiol. 52:1997;511-535.
57. Koh J., Yang L., Cotman C. Beta-amyloid protein increases that vulnerability of culture cortical neurons to excitotoxic damage. Brain Res. 53:1990;315-320.
58. Kordower J., Gach D.M., Bothwell M., Hersh L., Mufson E.J. Nerve growth factor receptor and choline acetyltransferase remain colocalized in the nucleus basalis of Alzheimer's patients. Neurobiol. Aging. 10:1989;67-74.
59. Kuner P., Hertel C. NGF induces apoptosis in a human neuroblastoma cell line expressing the neurotrophin receptor p75NTR. J. Neurosci. Res. 15:1998;465-474.
60. Kuner P., Schubenel R., Hertel C. Beta-amyloid binds to p57NTR and activates NF-kappa B in human cells. J. Neurosci. Res. 54:1998;798-804.
61. Lee K.F., Davies A.M., Jaenisch R. p75-deficient embryonic dorsal root sensory and neonatal sympathetic neurons display a decreased sensitivity to NGF. Development. 120:1994;1027-1033.
62. Li S., Mallory M., Alford M., Tanaka S., Masliah E. Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J. Neuropathol. Exp. Neurol. 56:1997;901-911.
63. Lin L., Leblanc C.J., Ceacon T.W., Isacson O. Chronic cognitive deficits and amyloid precursor protein elevation after selective immunotoxin lesions of the basal forebrain cholinergic system. NeuroReport. 9:1998;547-552.
64. Longo F.M., Manthorpe M., Xie Y.M., Varon S. Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor-dependent mechanism. J. Neurosci. Res. 48:1997;1-17.
65. Loo D.T., Copani A., Pike C.J., Whittemore E.R., Walencewicz A.J., Cotman C.W. Apoptosis is induced by b-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. U. S. A. 90:1993;7951-7955.
66. McGurk S.R., Levin E.D., Butcher L.L. Impairment of radial-arm maze performance in rats following lesions involving the cholinergic medial pathway - reversal by arecoline and differential-effects of muscarinic and nicotinic antagonists. Neuroscience. 44:1991;137-147.
67. Maragos W.F., Greenamyre J.T., Penney J.B., Young A.B. Glutamate dysfunction in Alzheimer's disease: a hypothesis. Trends Neurosci. 10:1987;65-68.
68. Mark R.J., Blanc E.M., Mattson M.P. Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease. Mol. Neurobiol. 12:1996;211-222.
69. Martin L.J., Al-Abdulla N.A., Brambrink A.M., Kirsch J.R., Sieber F.E., Portera-Cailliau C. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res. Bull. 46:1998;281-309.
70. Masliah E. Mechanisms of synaptic pathology in Alzheimer's disease. J. Neural. Transm., Suppl. 53:1998;147-158.
71. Muragaki Y., Chou T.T., Kaplan D.R., Trojanowski J.Q., Lee V.M.Y. Nerve Growth Factor induces apoptosis in human medulloblastoma cell lines that express trkA receptors. J. Neurosci. 17:1997;530-542.
72. Oh J.D., Woolf N.J., Roghani A., Edwards R.H., Butcher L.L. Cholinergic neurons in the rat central-nervous-system demonstrated by in-situ hybridization of choline-acetyltransferase messenger-RNA. Neuroscience. 47:1992;807-822.
73. Olney J.W., Wozniak D.F., Farber N.B. Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies. Arch. Neurol. 54:1997;1234-1240.
74. OrtunoSahagun D., BeasZarate C., AdameGonzalez G., FeriaVelasco A. Effect of L-glutamate on cholinergic neurotransmission in various brain regions and during the development of rats, when administered prenatally. Neurochem. Int. 31:1997;683-692.
75. Perry G., Nunomura A., Lucassen P., Lassmann H., Smith M.A. Apoptosis and Alzheimer's disease. Science. 282:1998;1268-1269.
76. Pflug B., Djakiew D. Expression of p75(NTR) in human prostate epithelial tumor cell line reduces nerve growth factor-induced cell growth by activation of programmed cell death. Mol. Carcinog. 23:1998;106-114.
77. Pioro E.P., Cuello A.C. Distribution of nerve growth factor receptor-like immunoreactivity in the adult rat central nervous system: effect of colchicine and correlation with cholinergic system. Neuroscience. 34:1990;57-87.
78. Portera-Cailliau C., Price D.L., Martin L.J. Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphological distinct: further evidence for an apoptosis-necrosis continuum. J. Comp. Neurol. 378:1997;88-104.
79. Price D.L., Sisodia S.S., Borchelt D.R. Genetic neurodegenerative diseases: the human illness and transgenic models. Neurodegeneration. 282:1998;1079-1082.
80. Qin Z.-H., Wang Y., Chase T.N. Stimulation of N-methyl-D-aspartate receptors induces apoptosis in rat brain. Brain Res. 725:1996;219-224.
81. Qin Z.-H., Wang Y., Nakai M., Chase T.N. Nuclear factor-kB contributes to excitotoxin-induced apoptosis in rat striatum. Mol. Pharmacol. 53:1998;33-42.
82. Rabizadeh S., Bitler C.M., Butcher L.L., Bredesen D.E. Expression Of the low-affinity nerve growth-factor receptor enhances beta-amyloid peptide toxicity. Proc. Natl. Acad. Sci. U. S. A. 91:1994;10703-10706.
83. Rabadizadeh S., Oh J., Ord T., Zhong L., Yang J., Bitler C.M., Butcher L.L., Bredesen D.E. Induction of apoptosis by low-affinity nerve growth factor receptor. Science. 261:1993;345-348.
84. Rende M., Provenzano C., Tonali P. Modulation of low-affinity NGFR in injures adult rat spinal cord motorneurons. J. Comp. Neurol. 338:1993;560-574.
85. Ruan Y.L., Rabizadeh S., Camerini D., Bredesen D.E. Expression of CD40 induces neural apoptosis. J. Neurosci. Res. 50:1997;383-390.
86. Salehi A., Verhaagen J., Dijkhuzen P.A., Swaab D.F. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience. 75:1996;373-387.
87. Salehi A., Verhaagen J., Swaab D.F. Neurotrophin receptors in Alzheimer's disease. Prog. Brain Res. 117:1998;71-78.
88. Scott H.L., Tannenberg A.E., Dodd P.R. Variant forms of neuronal glutamate transporter sites in Alzheimer's disease cerebral cortex. J. Neurochem. 64:1995;2193-2202.
89. Selkoe D.J. Amyloid protein and Alzheimer's disease. Sci. Am. 265:1991;68-78.
90. Simonian N.A., Getz R.L., Leveque J.C., Konradi C., Coyle J.T. Kainic acid induces apoptosis in neurons. Neuroscience. 75:1996;1047-1055.
91. Taglialatel G., Robinson R., PerezPolo J.R. Inhibition of nuclear factor kappa B (NF kappa B) activity induces nerve growth factor-resistant apoptosis in PC12 cells. J. Neurosci. Res. 47:1997;155-162.
92. Terai K., Matsuno A., McGeer P.L. Enhancement of immunoreactivity for NF-kB in the hippocampal formation and cerebral cortex of Alzheimer's disease. Brain Res. 735:1996;159-168.
93. Van der Zee C.E.E.M., Ross G.M., Riopelle R.J., Hagg T. Survival of cholinergic forebrain neurons in developing p75(NGFR)-deficient mice. Science. 274:1996;1729-1732.
94. Van der Zee C.E.E.M., Hagg T. p75(NGFR) mediates death of cholinergic neurons during postnatal development of the neostriatum in mice. J. Chem. Neuroanat. 14:1998;129-140.
95. Venero J.L., Hefti F. Regionally specific induction of BDNF and truncated trkB.T1 receptors in the hippocampal formation after intraseptal injection of kainic acid. Brain Res. 790:1998;270-277.
96. Verdi J.M., Birren S.J., Ibanez C.F., Persson H., Kaplan D.R., Benedetti M., Chao M.V., Anderson D.J. P75(LNGFR) regulates trk signal transduction and NGF-induced neuronal differentiation in MAH cells. Neuron. 12:1994;733-745.
97. Wainer B.H., Steininger T.L., Roback J.D., Burkewatson M.A., Mufson E.J., Kordower J. Ascending cholinergic pathways - Functional-organization and implications for disease-models. Prog. Brain Res. 98:1993;9-30.
98. Walsh T.J., Gandhi C., Stackman R.W. Reversible inactivation of the medial septum or nucleus basalis impairs working memory in rats: a dissociation of memory and performance. Behav. Neurosci. 112:1998;1114-1124.
99. Weiss J.H., Yin H.Z., Choi D.W. Basal forebrain cholinergic neurons are selectively vulnerable to AMPA/kainate receptor-mediated neurotoxicity. Neuroscience. 60:1994;659-664.
100. White W. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1996;1-15.
101. Williams L.R., Varon V.S., Peterson G.M., Wictorin K., Fischer W., Bjorklund A., Gage F.H. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc. Natl. Acad. Sci. U. S. A. 83:1986;9231-9235.
102. Woolf N.J., Gould E., Butcher L.L. Nerve growth factor receptor is associated with cholinergic neurons of the basal forebrain but not the pontomesencephalon. Neuroscience. 30:1989;143-152.
103. Woolf N.J., Jacobs R.W., Butcher L.L. The pontomesencephalotegmental cholinergic system does not degenerate in Alzheimer's-disease. Neurosci. Lett. 96:1989;277-282.
104. Yaar M., Zhai S., Pilch P.F., Doyle S.M., Eisenhauer P.B., Fine R.E., Gilchrest B.A. Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J. Clin. Invest. 100:1997;2333-2340.
105. Yao T.T., Chua-Couzens J., Butcher L.L., Bredesen D.E., Cooper J.D., Valletta J.S., Mobley W.C., Longo F.M. Absence of p75(NTR) causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation. J. Neurosci. 17:1997;7594-7605.
106. Yoon S.O., Casaccia-Bonnefil P., Carter B., Chao M.V. Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J. Neurosci. 18:1998;3273-3281.